01—Abstract
Summary
Summary of the 8-K filed May 1, 2025. Cited figures are marked; the original filing is the authoritative source.
On May 1, 2025, MicroStrategy Incorporated, doing business as Strategy (the "Company"), entered into a Sales Agreement with TD Securities (USA) LLC, The Benchmark Company, LLC, BTIG, LLC, Canaccord Genuity LLC, Cantor Fitzgerald & Co., Mizuho Securities USA LLC, Santander US Capital Markets LLC, and SG Americas Securities, LLC, as sales agents.
Under the agreement, the Company may issue and sell shares of its class A common stock, $0.001a par value, with an aggregate offering price of up to $21.0 billion through an at-the-market offering. The Company has no obligation to sell any shares. The Company also filed a prospectus supplement on May 1, 2025 under its existing automatic shelf registration statement, which became effective on January 27, 2025 (File No. 333-284510).
Offerings will be made only by means of that prospectus supplement. The Company has agreed to pay the agents commissions of up to 2.0%b of aggregate gross proceeds from each sale, along with customary indemnification and contribution rights. Sales may be suspended or terminated by the Company or the agents, and the agents act on a commercially reasonable efforts basis.
The filing also includes a legal opinion from Wilmer Cutler Pickering Hale and Dorr LLP relating to the shares, filed as Exhibit 5.1, with its consent included in the opinion. The full Sales Agreement is filed as Exhibit 1.1.
02—Key points
Key Highlights
- Entered a Sales Agreement with eight sales agents for an at-the-market equity offering of class A common stock with an aggregate offering price of up to $21.0 billion
- The Company has no obligation to sell any shares; sales will occur at times and amounts it determines
- Agents' commissions are up to 2.0% of aggregate gross proceeds from each share sale
- Shares are registered under an automatic shelf registration statement effective January 27, 2025 (File No. 333-284510) and offered via a prospectus supplement filed May 1, 2025
- The Company will sell shares through only one agent on any single day, and sales may be made through an agent's affiliate
- Offering may be suspended or terminated by either the Company or the agents upon notice
- Wilmer Cutler Pickering Hale and Dorr LLP issued a legal opinion on the shares (Exhibit 5.1)
03—Questions
Frequently Asked Questions
How large is the at-the-market offering?
The Sales Agreement covers the issuance and sale of class A common stock with an aggregate offering price of up to $21.0 billion.
Is the Company required to sell shares under this agreement?
No. The filing states the Company has no obligation to sell any of the shares and will determine the amounts and timing of any sales from time to time.
What fees will the Company pay the sales agents?
The Company has agreed to pay the agents commissions of up to 2.0% of the aggregate gross proceeds from each sale of its shares, and to provide customary indemnification and contribution rights.
How are the shares being registered and offered?
The shares are registered under the Company's existing automatic shelf registration statement, which became effective January 27, 2025 (File No. 333-284510). Offerings will be made only through the prospectus supplement filed on May 1, 2025.
Can the offering be stopped early?
Yes. The Company or the agents may suspend or terminate the offering upon notice to the other parties and subject to other conditions.
04—Continue